| Madhu Kiran H Murthy, MD | |
|
2375 E Camelback Rd Ste 600, Phoenix, AZ 85016-3493 | |
| (602) 551-8052 | |
| (602) 428-7025 |
| Full Name | Madhu Kiran H Murthy |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 5 Years |
| Location | 2375 E Camelback Rd Ste 600, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154532927 | NPI | - | NPPES |
| 359210 | Medicaid | AZ | |
| P02524386 | Other | MEDICARE RR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 5345 (Nebraska) | Secondary |
| 207RI0200X | Internal Medicine - Infectious Disease | 40424 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abrazo West Campus | Goodyear, AZ | Hospital |
| Abrazo Central Campus | Phoenix, AZ | Hospital |
| Valley View Hospital Association | Glenwood springs, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Einfectionmd Llc | 6406191543 | 15 |
| Einfectionmd Llc | 6406191543 | 15 |
| Dlp Marquette Physician Practices Inc | 9931359601 | 149 |
| Einfectionmd Llc | 6406191543 | 15 |
| Einfectionmd Llc | 6406191543 | 15 |
| Einfectionmd Llc | 6406191543 | 15 |
| Einfectionmd Llc | 6406191543 | 15 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that all preliminary due diligence is now complete for the acquisition of controlling interest in BioCells, Inc. BioCells is headquartered in Argentina, with affiliates under development in Peru, Colombia, Bolivia, Panama and Puerto Rico. The acquisition is expected to be closed no later than August 31, 2010.
Transgenomic, Inc. and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM) today announced the advance on-line publication of a clinical research paper entitled "Abnormal Serum Concentrations of Proteins in Parkinson's Disease" in the scientific journal Biochemical and Biophysical Research Communications.
Nicoletta Sonino and associates, in the current issue of the Journal of Clinical Endocrinology & Metabolism, point to the importance of including illness behavior (the ways in which people experience, perceive, evaluate and respond to their own health status) in the evaluation of patients with hormone disorders.
It has been known that countries with rapidly developing economies may experience a double-disease burden that results from undernutrition and overnutrition.
Cordis Endovascular today reported the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) recommended approval of the company's new Cordis Carotid System. Cordis Endovascular is a division of Cordis Corporation, a Johnson & Johnson company.
› Verified 9 days ago
| Entity Name | Ctca Physicians Group Of Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609026806 PECOS PAC ID: 2264593474 Enrollment ID: O20081205000793 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that all preliminary due diligence is now complete for the acquisition of controlling interest in BioCells, Inc. BioCells is headquartered in Argentina, with affiliates under development in Peru, Colombia, Bolivia, Panama and Puerto Rico. The acquisition is expected to be closed no later than August 31, 2010.
Transgenomic, Inc. and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM) today announced the advance on-line publication of a clinical research paper entitled "Abnormal Serum Concentrations of Proteins in Parkinson's Disease" in the scientific journal Biochemical and Biophysical Research Communications.
Nicoletta Sonino and associates, in the current issue of the Journal of Clinical Endocrinology & Metabolism, point to the importance of including illness behavior (the ways in which people experience, perceive, evaluate and respond to their own health status) in the evaluation of patients with hormone disorders.
It has been known that countries with rapidly developing economies may experience a double-disease burden that results from undernutrition and overnutrition.
Cordis Endovascular today reported the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) recommended approval of the company's new Cordis Carotid System. Cordis Endovascular is a division of Cordis Corporation, a Johnson & Johnson company.
› Verified 9 days ago
| Entity Name | Metro Infectious Disease Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235125717 PECOS PAC ID: 3072425784 Enrollment ID: O20130320000724 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that all preliminary due diligence is now complete for the acquisition of controlling interest in BioCells, Inc. BioCells is headquartered in Argentina, with affiliates under development in Peru, Colombia, Bolivia, Panama and Puerto Rico. The acquisition is expected to be closed no later than August 31, 2010.
Transgenomic, Inc. and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM) today announced the advance on-line publication of a clinical research paper entitled "Abnormal Serum Concentrations of Proteins in Parkinson's Disease" in the scientific journal Biochemical and Biophysical Research Communications.
Nicoletta Sonino and associates, in the current issue of the Journal of Clinical Endocrinology & Metabolism, point to the importance of including illness behavior (the ways in which people experience, perceive, evaluate and respond to their own health status) in the evaluation of patients with hormone disorders.
It has been known that countries with rapidly developing economies may experience a double-disease burden that results from undernutrition and overnutrition.
Cordis Endovascular today reported the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) recommended approval of the company's new Cordis Carotid System. Cordis Endovascular is a division of Cordis Corporation, a Johnson & Johnson company.
› Verified 9 days ago
| Entity Name | Einfectionmd Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417437526 PECOS PAC ID: 6406191543 Enrollment ID: O20181218003680 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that all preliminary due diligence is now complete for the acquisition of controlling interest in BioCells, Inc. BioCells is headquartered in Argentina, with affiliates under development in Peru, Colombia, Bolivia, Panama and Puerto Rico. The acquisition is expected to be closed no later than August 31, 2010.
Transgenomic, Inc. and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM) today announced the advance on-line publication of a clinical research paper entitled "Abnormal Serum Concentrations of Proteins in Parkinson's Disease" in the scientific journal Biochemical and Biophysical Research Communications.
Nicoletta Sonino and associates, in the current issue of the Journal of Clinical Endocrinology & Metabolism, point to the importance of including illness behavior (the ways in which people experience, perceive, evaluate and respond to their own health status) in the evaluation of patients with hormone disorders.
It has been known that countries with rapidly developing economies may experience a double-disease burden that results from undernutrition and overnutrition.
Cordis Endovascular today reported the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) recommended approval of the company's new Cordis Carotid System. Cordis Endovascular is a division of Cordis Corporation, a Johnson & Johnson company.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Madhu Kiran H Murthy, MD 2375 E Camelback Rd Ste 600, Phoenix, AZ 85016-3493 Ph: (602) 551-8052 | Madhu Kiran H Murthy, MD 2375 E Camelback Rd Ste 600, Phoenix, AZ 85016-3493 Ph: (602) 551-8052 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that all preliminary due diligence is now complete for the acquisition of controlling interest in BioCells, Inc. BioCells is headquartered in Argentina, with affiliates under development in Peru, Colombia, Bolivia, Panama and Puerto Rico. The acquisition is expected to be closed no later than August 31, 2010.
Transgenomic, Inc. and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM) today announced the advance on-line publication of a clinical research paper entitled "Abnormal Serum Concentrations of Proteins in Parkinson's Disease" in the scientific journal Biochemical and Biophysical Research Communications.
Nicoletta Sonino and associates, in the current issue of the Journal of Clinical Endocrinology & Metabolism, point to the importance of including illness behavior (the ways in which people experience, perceive, evaluate and respond to their own health status) in the evaluation of patients with hormone disorders.
It has been known that countries with rapidly developing economies may experience a double-disease burden that results from undernutrition and overnutrition.
Cordis Endovascular today reported the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) recommended approval of the company's new Cordis Carotid System. Cordis Endovascular is a division of Cordis Corporation, a Johnson & Johnson company.
› Verified 9 days ago
Moustafa I Hazin, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 500 W Thomas Rd, Suite 900, Phoenix, AZ 85013 Phone: 602-406-5590 Fax: 602-406-7165 | |
Dr. Ali Shaheen Al-yaqoobi, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 2601 E Roosevelt St, Phoenix, AZ 85008 Phone: 602-344-5411 | |
Dana Archbold, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1111 E Mcdowell Rd, Phoenix, AZ 85006 Phone: 602-839-2296 Fax: 602-839-2084 | |
Catalina Nicole Flores, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 350 W Thomas Rd Dept Of, Phoenix, AZ 85013 Phone: 602-406-3000 | |
Kristina Yancey, Infectious Disease Medicare: Medicare Enrolled Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-342-2000 | |
Dr. Francisco Cordova, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 29 W Edgemont Ave, Phoenix, AZ 85003 Phone: 602-263-8971 Fax: 602-263-8971 | |
Dr. Dimpy Kapoor, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9305 W Thomas Rd, Ste 455, Phoenix, AZ 85037 Phone: 623-399-9010 Fax: 623-399-9013 |